PSEUDOMONAS AERUGINOSA EXPLOITS LIPID A AND MUROPEPTIDES MODIFICATION AS A STRATEGY TO LOWER INNATE IMMUNITY DURING CF CHRONIC LUNG INFECTION

被引:0
|
作者
Cigana, C. [1 ]
Lore, N. [1 ]
Leone, M.
Ierano, T. [2 ]
Curcuru, L. [2 ,3 ]
Tummler, B. [4 ]
Bianconi, I. [1 ]
Molinaro, A. [2 ]
Bernardini, M. [3 ]
Bragonzi, A. [1 ]
机构
[1] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy
[2] Univ Naples Federico 2, Dept Organ Chem & Biochem, Naples, Italy
[3] Univ Roma La Sapienza, Dept Cellular & Dev Biol, Rome, Italy
[4] Hannover Med Sch, Klin Forschergrp, D-30623 Hannover, Germany
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
350
引用
收藏
页码:334 / 334
页数:1
相关论文
共 31 条
  • [31] The anti-sigma factor MucA of Pseudomonas aeruginosa: Dramatic differences of a mucA22 vs. a ΔmucA mutant in anaerobic acidified nitrite sensitivity of planktonic and biofilm bacteria in vitro and during chronic murine lung infection
    Panmanee, Warunya
    Su, Shengchang
    Schurr, Michael J.
    Lau, Gee W.
    Zhu, Xiaoting
    Ren, Zhaowei
    McDaniel, Cameron T.
    Lu, Long J.
    Ohman, Dennis E.
    Muruve, Daniel A.
    Panos, Ralph J.
    Ye, Hongwei D.
    Thompson, Thomas B.
    Tseng, Boo Shan
    Hassett, Daniel J.
    PLOS ONE, 2019, 14 (06):